STRS Ohio’s Eterna Therapeutics ERNA Stock Holding History

STRS Ohio’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	-$13K	–	2114
2022 Q1	$13K	Hold	1	–	–	﹤0.01%	2073
2021 Q4	$28K	Hold	1	–	–	﹤0.01%	2077
2021 Q3	$63K	Hold	1	–	–	﹤0.01%	2029
2021 Q2	$99K	Buy	+1	New	+$144K	﹤0.01%	1979

Other funds holding ERNA

CPWM

Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return

Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's ERNA Position: Q2 2022 in Review

STRS Ohio sold out of Eterna Therapeutics (ERNA) in Q2 2022, closing a stake of 1 share — an estimated $13K sold.

STRS Ohio first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $99K in Q2 2021. 34 funds tracked by Wall St. Rank hold ERNA as of Q2 2022.

STRS Ohio reported no remaining Eterna Therapeutics position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 1 Eterna Therapeutics share in Q2 2022, an estimated $13K.
STRS Ohio first reported a position in Eterna Therapeutics in Q2 2021 and held it in 4 quarters.
STRS Ohio's Eterna Therapeutics position peaked at $99K in Q2 2021.
34 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.